
Diabetes & Endocrinologybiomarkersmetabolomics
Predicting Long-Term Mortality: Insights from a Multi-Metabolite Signature in the PREDIMED Trial
By MedXY|Oct 2, 2025
A study identified a robust plasma multi-metabolite signature that predicts long-term all-cause mortality in participants from the PREDIMED trial and several US cohorts, providing new insights into metabolic biomarkers.